Valsartan in Combination with Tripterygium Glycosides Protects against Chronic Nephritis via the Toll-Like Receptor 4 Pathway

Table 6

Percentage of T-lymphocyte subpopulations before and after treatment in both groups.

Groups	CD4+ (%)	CD8+ (%)	CD4+/CD8+
Control group ()
Before treatment
After treatment
Observation group ()
Before treatment
After treatment	^#	^#	^#

Note: vs. the before treatment; ^# vs. the control group.